Baroda BNP Paribas Conservative Hybrid
The scheme aims to generate regular returns through investment primarily in debt and money market instruments. It would also invest a portion of its assets in equity and equity related securities to generate long term appreciation.
Growthvine rating: 2/5 — ranked #15 of 24 in category.
Fund basics
| Category | Hybrid: Conservative |
|---|
| NAV | ₹46.10 (as of 2026-10-01) |
|---|
| AUM | ₹944 Cr |
|---|
| Expense ratio | 1.70% |
|---|
| Riskometer | Moderately High |
|---|
| Fund manager | Ankeet Pandya |
|---|
| Exit load | 1% for redemption within 180 days |
|---|
Performance & risk
| Sharpe ratio | 0.37 |
|---|
| Standard deviation | 4.11% |
|---|
| Max drawdown | −4.77% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 106.3% of NIFTY 50 Hybrid Composite Debt 15:85 Index's upside and 101.3% of its downside.
Market cap allocation
| Large cap | 56.9% |
|---|
| Mid cap | 23.5% |
|---|
| Small cap | 19.6% |
|---|
Concentration
| Top 5 holdings | 3.8% |
|---|
| Top 10 holdings | 6.6% |
|---|
| Total holdings | 46 |
|---|
Top holdings
- Clearing Corporation of India Ltd — 6.1%
- 8.95% Reliance Industries Limited (09/11/2028) — 5.0%
- 7.44% Power Finance Corporation Limited (15/01/2030) — 4.5%
- 7.59% National Housing Bank (08/09/2027) — 2.7%
- 7.23% UltraTech Cement Limited (01/02/2030) — 2.6%
- 7.53% Bajaj Housing Finance Limited (28/09/2029) — 2.4%
- 8.7% Shriram Finance Limited (09/04/2028) — 2.2%
- 7.7% Bajaj Housing Finance Limited (21/05/2027) — 2.1%
- Net Receivables / (Payables) — 2.1%
- 7.97% Mankind Pharma Limited (16/11/2027) — 2.0%
Top sectors
Not disclosed.
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 0.9% | Q2 | #7 of 20 |
| 2025 | 5.3% | Q3 | #14 of 20 |
| 2024 | 9.8% | Q3 | #13 of 20 |
| 2023 | 11.0% | Q3 | #12 of 20 |